// App-Quantinova.ai

2086 : Noscapine chemosensitization enhances docetaxel anticancer activity and tumor stroma disruption against triple negative breast cancer

Researchers

Presenter

  • Ravi Doddapaneni

Principal Investigators

  • Ketan Patel

  • Nusrat Chowdhury

  • Mandip Sachdeva

Medical Centers

  • Florida A&M University, Tallahassee, FL.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Phosphorylated c-Jun N-terminal kinase

Drug/Treatment

  • CB-3304

  • Docetaxel

  • CS-359

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved